The DOI matches its Crossref record.
Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Only two RCTs were identified for NSAIDs, one of which evaluated rofecoxib 75 (now withdrawn from the market). The second RCT evaluated celecoxib in patients with CP/CPPS, with a statistically significant decrease in NIH‐CPSI total (P < 0.015), pain (P < 0.006) and QoL (P < 0.032) scores after 2, 4 and 6 weeks; however, the effects were limited to the short duration of therapy 76.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [76]
In the citing paper
“The second RCT evaluated celecoxib in patients with CP/CPPS, with a statistically significant decrease in NIH‐CPSI total (P < 0.015), pain (P < 0.006) and QoL (P < 0.032) scores after 2, 4 and 6 weeks; however, the effects were limited to the short duration of therapy 76.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 20
- McNaughton Collins M, 2001, Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network, J Gen Intern Med, 16, 656, 10.1111/j.1525-1497.2001.01223.x · DOI · Paper page
- Krieger JN, 1999, NIH consensus definition and classification of prostatitis, JAMA, 282, 236, 10.1001/jama.282.3.236 · DOI · Paper page
- Nickel JC, 2002, Prostatitis and related conditions, 603
- Cornel EB, 2005, The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III, Eur Urol, 47, 607, 10.1016/j.eururo.2004.12.014 · DOI · Paper page
- Elist J, 2006, Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study, Urology, 67, 60, 10.1016/j.urology.2005.07.035 · DOI
- Ziaee AM, 2006, Effect of allopurinol in chronic nonbacterial prostatitis: a double blind randomized clinical trial, Int Braz J Urol, 32, 181, 10.1590/S1677-55382006000200008 · doi:10.1590/s1677-55382006000200008
- Ateya A, 2006, Evaluation of prostatic massage in treatment of chronic prostatitis, Urology, 67, 674, 10.1016/j.urology.2005.10.021 · DOI · Paper page
- Shoskes DA, 2003, Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome, J Urol, 169, 1406, 10.1097/01.ju.0000055549.95490.3c · DOI
- Alexander RB, 1998, Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome, Urology, 52, 744, 10.1016/S0090-4295(98)00390-2 · DOI · Paper page
- Spaziani EP, 1996, The induction of cyclooxygenase-2 (COX-2) in intact human amnion tissue by interleukin-4, Prostaglandins, 51, 215, 10.1016/0090-6980(96)00005-6 · DOI
- Arber N, 2006, Celecoxib for the prevention of colorectal adenomatous polyps, N Engl J Med, 355, 885, 10.1056/NEJMoa061652 · DOI · Paper page
- Nickel JC, 1996, Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires, J Urol, 155, 1950, 10.1016/S0022-5347(01)66056-7 · doi:10.1016/s0022-5347(01)66056-7
- Nickel JC, 2003, A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis, J Urol, 169, 1401, 10.1097/01.ju.0000054983.45096.16 · DOI
- Propert KJ, 2002, Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome, Urology, 59, 870, 10.1016/S0090-4295(02)01601-1 · doi:10.1016/s0090-4295(02)01601-1
- Chen R, 2003, Acupuncture ameliorates symptoms in men with chronic prostatitis/chronic pelvic pain syndrome, Urology, 61, 1156, 10.1016/S0090-4295(03)00141-9 · DOI · Paper page
- Orhan I, 2001, Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome, Int J Urol, 8, 495, 10.1046/j.1442-2042.2001.00358.x · doi:10.1046/j.1442-2042.2001.00358.x
- Miller LJ, 2002, Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome, J Urol, 167, 753, 10.1016/S0022-5347(01)69139-0 · DOI
- Zeng X, 2004, [Clinical evaluation of celecoxib in treating type IIIA chronic prostatitis], Zhonghua Nan Ke Xue, 10, 278
- Kirby RS, 1982, Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis, Br J Urol, 54, 729, 10.1111/j.1464-410X.1982.tb13635.x · doi:10.1111/j.1464-410x.1982.tb13635.x
- Schaeffer AJ, 2006, Clinical practice: Chronic prostatitis and the chronic pelvic pain syndrome, N Engl J Med, 355, 1690, 10.1056/NEJMcp060423 · DOI · Paper page
Cited by
Rees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG) (2015) · BJU International · doi:10.1111/bju.13101 · Cited by 371
Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Magistro, G., Wagenlehner, F. M. E., Grabe, M., Weidner, W., Stief, C. G., & Nickel, J. C. (2016) · European Urology · doi:10.1016/j.eururo.2015.08.061 · Cited by 294
Anothaisintawee, T. (2011) · JAMA · doi:10.1001/jama.2010.1913 · Cited by 278
Rajguru, P., Kolber, M. J., Garcia, A. N., Smith, M. T., Patel, C. K., & Hanney, W. J. (2015) · American Journal of Lifestyle Medicine · doi:10.1177/1559827614522580 · Cited by 18
Metadata
- Authors
- Zhao, W. P., Zhang, Z. G., Li, X. D., Yu, D., Rui, X. F., Li, G. H., & Ding, G. Q.
- Affiliations
- Medical College of Zhejiang University, China
- Venue
- Brazilian Journal of Medical and Biological Research
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2009-09-04
- Volume
- 42
- Issue
- 10
- Pages
- 963-967
- ISSN
- 1414-431X
- 0100-879X
- Cited by
- 56
- References
- 0
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA). https://app.cochat.ai/papers/10.1590/s0100-879x2009005000021
- The paper
- Zhao, W. P., Zhang, Z. G., Li, X. D., Yu, D., Rui, X. F., Li, G. H., & Ding, G. Q. (2009). Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA). Brazilian Journal of Medical and Biological Research. https://doi.org/10.1590/s0100-879x2009005000021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.